Becton, Dickinson and Company (BDX) Stock Analysis — Fair Value, Risk & Moat Rating
NYQ · Healthcare · Medical Instruments & Supplies
Is Becton, Dickinson and Company a safe investment right now?
Becton, Dickinson and Company's Altman Z-Score of 2.11 places it in the gray zone. Our fair value estimate is $166.32 (Watch Zone). Moat rating: 2.6/5 stars.
Could Becton, Dickinson and Company go bankrupt? Altman Z-Score analysis
Z-Score of 2.11 places the company in the gray zone (1.8-3.0), warranting closer scrutiny.
- Below 1.8 — Distress Zone (high bankruptcy risk)
- 1.8 to 3.0 — Gray Zone (elevated uncertainty)
- Above 3.0 — Safe Zone (financially healthy)
What drives BDX's Z-Score?
| Component | Formula | Value | Weight | Contribution |
|---|---|---|---|---|
| A · Working Capital / Total Assets | WC / TA | 0.017 | 1.2 | 0.02 |
| B · Retained Earnings / Total Assets | RE / TA | 0.3004 | 1.4 | 0.42 |
| C · EBIT / Total Assets | EBIT / TA | 0.0451 | 3.3 | 0.15 |
| D · Market Cap / Total Liabilities | MCap / TL | 1.8838 | 0.6 | 1.13 |
| E · Revenue / Total Assets | Rev / TA | 0.3948 | 1.0 | 0.39 |
How has BDX's financial health changed over time?
| Year | Z-Score | Zone |
|---|---|---|
| 2022 | 2.12 | Gray |
| 2023 | 2.21 | Gray |
| 2024 | 2.0 | Gray |
| 2025 | 2.11 | Gray |
Source: Calculated from BDX's latest 10-K filing on SEC EDGAR.
What is Becton, Dickinson and Company actually worth?
How we calculated this
| Input | Value | Source |
|---|---|---|
| Predicted EPS (α) | $7.70 | Proprietary blend of reported actuals (1Q actual) + analyst consensus, weighted by α |
| Last Year EPS | $5.82 | Annual report (SEC EDGAR) |
| Analyst Consensus EPS (This Year) | $12.47 | 13 analysts consensus |
| Trailing P/E | 25.4x | Current market pricing |
| Fair P/E (β discount) | 21.6x | Trailing PE adjusted by value discount factor β, hard-capped |
| Earnings Trend (γ) | Accelerating | Directional signal: predicted vs trailing EPS |
Wall Street Reference: Analyst consensus target price is $191.46 (13 analysts). This is shown for reference only and is not used in our valuation model.
Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.
Does Becton, Dickinson and Company have a durable competitive advantage?
Moat rating: 2.6/5.
What makes up BDX's moat score?
ROIC Stability
ROIC variability over the past decade. Score: 2/5.
Gross Margin Trend
Gross margin trajectory over the past decade. Score: 3/5.
Switching Costs
Estimated customer lock-in based on margin level. Score: 3/5.
How stable is BDX's return on invested capital?
| Year | ROIC | Trend |
|---|---|---|
| 2022 | 5.3% | — |
| 2023 | 5.1% | Stable |
| 2024 | 5.5% | Stable |
| 2025 | 5.6% | Stable |
Source: ROIC calculated from SEC EDGAR filings.
Is Becton, Dickinson and Company's dividend safe?
Can Becton, Dickinson and Company afford its dividend?
Payout ratio is 68.1%. FCF covers the dividend 1.5x. 45 consecutive years of payments.
Becton, Dickinson and Company's key financial metrics
| Metric | Latest | 1Y Ago | 3Y Ago | Trend |
|---|---|---|---|---|
| Revenue | $21.8B | $20.2B | $18.9B | Rising |
| Net Income | $1.7B | $1.7B | $1.8B | Declining |
| Free Cash Flow | $2.7B | $3.1B | $1.7B | Rising |
| Gross Margin | 45.4% | 45.2% | 44.9% | Stable |
Recent events that affect our BDX analysis
BDX earnings report scheduled
Upcoming report. Consensus EPS estimate: $2.78. Revenue estimate: $4.67B. Our current Fair Value: $166.32 — a significant beat or miss could shift this estimate.
BDX analyst consensus: 33% bullish (5 of 15 analysts)
1 Strong Buy, 4 Buy, 10 Hold, 0 Sell, 0 Strong Sell. Consensus target: $191.46 (23.0% upside). Compare with our independent Fair Value: $166.32.
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX paid $1.0500/share dividend
Dividend Safety Grade: A. Payout ratio: 68.1%.
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX stock split 1:1
Stock splits don't change fundamental value, but they can affect per-share metrics. Our models automatically adjust for splits.
BDX beat EPS estimates by 3.9%
Reported EPS: $2.91 vs estimate $2.80. Earnings strength supports our Fair Value of $166.32 (6.9% above current price).
BDX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX paid $0.8255/share dividend
Dividend Safety Grade: A. Payout ratio: 68.1%.
BDX filed annual report (10-K)
Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX beat EPS estimates by 1.1%
Reported EPS: $3.96 vs estimate $3.91. Earnings strength supports our Fair Value of $166.32 (6.9% above current price).
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX paid $0.8176/share dividend
Dividend Safety Grade: A. Payout ratio: 68.1%.
BDX beat EPS estimates by 8.2%
Reported EPS: $3.68 vs estimate $3.40. Earnings strength supports our Fair Value of $166.32 (6.9% above current price).
BDX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX paid $0.8176/share dividend
Dividend Safety Grade: A. Payout ratio: 68.1%.
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX beat EPS estimates by 2.1%
Reported EPS: $3.35 vs estimate $3.28. Earnings strength supports our Fair Value of $166.32 (6.9% above current price).
BDX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX paid $0.8176/share dividend
Dividend Safety Grade: A. Payout ratio: 68.1%.
BDX filed quarterly report (10-Q)
Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →
BDX beat EPS estimates by 14.7%
Reported EPS: $3.43 vs estimate $2.99. Earnings strength supports our Fair Value of $166.32 (6.9% above current price).
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
BDX filed 8-K (material event)
8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →
Common questions about Becton, Dickinson and Company
What is Becton, Dickinson and Company stock price today?
Becton, Dickinson and Company (BDX) stock price is $155.65 as of the latest market close, traded on the NYSE exchange.
What does Becton, Dickinson and Company do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems.
What is Becton, Dickinson and Company market cap?
Becton, Dickinson and Company has a market capitalization of $56.39B, classifying it as a large-cap stock in the Healthcare sector.
What sector and industry is BDX in?
Becton, Dickinson and Company operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. It trades on the NYSE under the ticker symbol BDX.
Is BDX stock overvalued or undervalued?
Based on our valuation model, Becton, Dickinson and Company trades 6.4% below our fair value estimate — potentially undervalued.
- FairValueLabs Fair Value: $166.32
- Current Price: $155.65
- Valuation Zone: Watch Zone
What is BDX stock forecast and analyst target price?
Based on 13 Wall Street analysts, the consensus price target for Becton, Dickinson and Company is $191.46, implying upside of 23.0% from the current price.
- Analyst High Target: $225.00
- Analyst Low Target: $157.00
Note: Analyst targets are shown for reference and are not used in our valuation model.
Is Becton, Dickinson and Company revenue and earnings growing?
Here are the analyst consensus growth estimates for Becton, Dickinson and Company:
- Revenue growth (current year est.): -12.3%
- EPS growth (current year est.): -13.4%
- Revenue growth (next year est.): 2.9%
- EPS growth (next year est.): 8.3%
What are Becton, Dickinson and Company's key financial metrics?
| Metric | Latest | Trend |
|---|---|---|
| Revenue | $21.8B | Rising |
| Net Income | $1.7B | Declining |
| Free Cash Flow | $2.7B | Rising |
| Gross Margin | 45.4% | Stable |
What is BDX's P/E ratio?
The price-to-earnings ratio measures how much investors pay per dollar of earnings:
- Trailing P/E (last 12 months): 25.4x
- Forward P/E (next 12 months est.): 11.5x
- FairValueLabs Fair P/E: 21.6x
How volatile is BDX stock?
Becton, Dickinson and Company has a beta of 0.35, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.
How much cash and debt does Becton, Dickinson and Company have?
Becton, Dickinson and Company's balance sheet shows:
- Total Cash: $751.0M
- Total Debt: $19.54B
- Net Cash Position: $-18.79B
A positive net cash position means the company holds more cash than debt, reducing financial risk.
What is Becton, Dickinson and Company's free cash flow?
Becton, Dickinson and Company generated $3.11B in trailing twelve-month free cash flow (from $3.39B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.
Does Becton, Dickinson and Company pay a dividend, and is it safe?
Yes, Becton, Dickinson and Company pays a regular dividend. Here are the key metrics:
- Dividend Yield: 2.7%
- Payout Ratio: 68.1%
- Consecutive Years Paid: 45
- 5-Year Dividend Growth: -16.4%
- FairValueLabs Safety Grade: A
Is Becton, Dickinson and Company at risk of going bankrupt?
Becton, Dickinson and Company's Altman Z-Score is 2.11, placing it in the gray zone (1.8–3.0) — some financial uncertainty. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.
Does Becton, Dickinson and Company have a durable competitive advantage?
Becton, Dickinson and Company scores 2.6/5 stars (Narrow moat · eroding) in our moat analysis:
- ROIC Stability: 2/5
- Gross Margin Trend: 3/5
- Switching Costs: 3/5
A score above 3.5 suggests meaningful pricing power and a defensible market position.
What is BDX's return on equity (ROE)?
Becton, Dickinson and Company's return on equity is 7.0%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.
How do I buy BDX stock?
BDX shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:
- Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
- Search for ticker symbol BDX
- Place a market or limit order for your desired number of shares
This is not investment advice. Always do your own research before buying any stock.
Is BDX a value stock or speculative?
FairValueLabs classifies Becton, Dickinson and Company as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.
Who is the CEO of Becton, Dickinson and Company?
The current CEO of Becton, Dickinson and Company is Mr. Thomas E. Polen Jr..
What is BDX's earnings per share (EPS)?
Earnings per share measures the company's profit allocated to each outstanding share:
- Trailing EPS (last 12 months): $6.12
- Forward EPS (next 12 months est.): $13.50
- Analyst consensus EPS (this year): $12.47
- Analyst consensus EPS (next year): $13.50
Other Healthcare companies analyzed by FairValueLabs
FairValueLabs Disclaimer
All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.
This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.
Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.
BDX analysis methodology: How we calculate fair value, Z-Scores, and moat ratings